BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21839070)

  • 1. Selective histamine H₃ and H₄ receptor agonists exert opposite effects against the gastric lesions induced by HCl in the rat stomach.
    Coruzzi G; Adami M; Pozzoli C; de Esch IJ; Smits R; Leurs R
    Eur J Pharmacol; 2011 Nov; 669(1-3):121-7. PubMed ID: 21839070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine H(3) receptors are involved in the protective effect of ghrelin against HCl-induced gastric damage in rats.
    Adami M; Pozzoli C; Leurs R; Stark H; Coruzzi G
    Pharmacology; 2010; 86(5-6):259-66. PubMed ID: 20975320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of histamine H4 receptor ligands in a mouse model of gastric ulceration.
    Adami M; Pozzoli C; Menozzi A; Bertini S; Passeri B; Cantoni AM; Smits R; de Esch I; Leurs R; Coruzzi G
    Pharmacology; 2012; 89(5-6):287-94. PubMed ID: 22538763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine H(3)-receptor antagonists inhibit gastroprotection by (R)-alpha-methylhistamine in the rat.
    Morini G; Grandi D; Stark H; Schunack W
    Br J Pharmacol; 2000 Apr; 129(8):1597-600. PubMed ID: 10780963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands.
    Kottke T; Sander K; Weizel L; Schneider EH; Seifert R; Stark H
    Eur J Pharmacol; 2011 Mar; 654(3):200-8. PubMed ID: 21237145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.
    Kitbunnadaj R; Zuiderveld OP; De Esch IJ; Vollinga RC; Bakker R; Lutz M; Spek AL; Cavoy E; Deltent MF; Menge WM; Timmerman H; Leurs R
    J Med Chem; 2003 Dec; 46(25):5445-57. PubMed ID: 14640553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptor.
    Ito S; Yoshimoto R; Miyamoto Y; Mitobe Y; Nakamura T; Ishihara A; MacNeil DJ; Kanatani A; Tokita S
    Eur J Pharmacol; 2006 Jan; 529(1-3):40-6. PubMed ID: 16316645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.
    Witte DG; Yao BB; Miller TR; Carr TL; Cassar S; Sharma R; Faghih R; Surber BW; Esbenshade TA; Hancock AA; Krueger KM
    Br J Pharmacol; 2006 Jul; 148(5):657-70. PubMed ID: 16715122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist.
    Kitbunnadaj R; Hashimoto T; Poli E; Zuiderveld OP; Menozzi A; Hidaka R; de Esch IJ; Bakker RA; Menge WM; Yamatodani A; Coruzzi G; Timmerman H; Leurs R
    J Med Chem; 2005 Mar; 48(6):2100-7. PubMed ID: 15771452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and functional characterization of imbutamine analogs as histamine H3 and H4 receptor ligands.
    Geyer R; Kaske M; Baumeister P; Buschauer A
    Arch Pharm (Weinheim); 2014 Feb; 347(2):77-88. PubMed ID: 24493592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine H(4) receptor antagonist ameliorates chronic allergic contact dermatitis induced by repeated challenge.
    Seike M; Furuya K; Omura M; Hamada-Watanabe K; Matsushita A; Ohtsu H
    Allergy; 2010 Mar; 65(3):319-26. PubMed ID: 19886918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of histaminergic receptor mechanisms in the stimulation of NT-3 synthesis in astrocytes.
    Jurič DM; Mele T; Carman-Kržan M
    Neuropharmacology; 2011 Jun; 60(7-8):1309-17. PubMed ID: 21276809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and characterization of a novel human histamine receptor.
    Morse KL; Behan J; Laz TM; West RE; Greenfeder SA; Anthes JC; Umland S; Wan Y; Hipkin RW; Gonsiorek W; Shin N; Gustafson EL; Qiao X; Wang S; Hedrick JA; Greene J; Bayne M; Monsma FJ
    J Pharmacol Exp Ther; 2001 Mar; 296(3):1058-66. PubMed ID: 11181941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homologous down-regulation of histamine H3 receptors in rat striatal slices.
    Garduño-Torres B; Arias-Montaño JA
    Synapse; 2006 Aug; 60(2):165-71. PubMed ID: 16715497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.
    Lim HD; van Rijn RM; Ling P; Bakker RA; Thurmond RL; Leurs R
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1310-21. PubMed ID: 15947036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INCB38579, a novel and potent histamine H₄ receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functions.
    Shin N; Covington M; Bian D; Zhuo J; Bowman K; Li Y; Soloviev M; Qian DQ; Feldman P; Leffet L; He X; He Wang K; Krug K; Bell D; Czerniak P; Hu Z; Zhao H; Zhang J; Yeleswaram S; Yao W; Newton R; Scherle P
    Eur J Pharmacol; 2012 Jan; 675(1-3):47-56. PubMed ID: 22155710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological properties of histamine receptor subtypes.
    Arrang JM
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):275-81. PubMed ID: 7920174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclopropane-based stereochemical diversity-oriented conformational restriction strategy: histamine H3 and/or H4 receptor ligands with the 2,3-methanobutane backbone.
    Watanabe M; Kobayashi T; Hirokawa T; Yoshida A; Ito Y; Yamada S; Orimoto N; Yamasaki Y; Arisawa M; Shuto S
    Org Biomol Chem; 2012 Jan; 10(4):736-45. PubMed ID: 22120611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.
    Deml KF; Beermann S; Neumann D; Strasser A; Seifert R
    Mol Pharmacol; 2009 Nov; 76(5):1019-30. PubMed ID: 19720730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
    McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.